SABIC Q3 2025 results and project progress
- Q3 revenue was US$9.2 Bn, down 3% versus Q2 2025.
- Adjusted EBITDA was US$1.3 Bn with a 14.5% margin; adjusted net income was US$186 Mn, up 45% versus Q2.
- MTBE plant in KSA started ahead of plan with 1,000 KTA capacity and a SABIC‑licensed Dehydrogenation Unit.
- Sabic Fujian project is 87% EPC complete, invested US$6.4 Bn, with start-up of all units planned for Q3 2026.
Navigating global conditions
Global GDP growth settled at 2.6% in Q3 2025. Manufacturing PMI showed some improvement with expansion in Europe and China, while overcapacity persists in the petrochemicals industry.
Mega project execution
The MTBE project in KSA achieved start‑up ahead of plan and is the largest single MTBE plant globally with a 1,000 KTA nameplate capacity and a SABIC‑licensed Dehydrogenation Unit. The Sabic Fujian project in China is 87% complete on EPC progress, with total investment of US$6.4 Bn, 16 production units and a 1.8 MMT mixed‑feed steam cracker; start‑up of all units is planned for Q3 2026.
Q3 financials
Q3 2025 revenue was US$9.2 Bn, 3% lower than Q2 2025. Adjusted EBITDA was US$1.3 Bn with an adjusted EBITDA margin of 14.5%. Adjusted net income was US$186 Mn, up 45% versus Q2. Year‑to‑date adjusted EBITDA was US$3.7 Bn; cash flow from operations was US$2.7 Bn in the first nine months and net debt was US$‑0.2 Bn.
Operational transformation and outlook
Excluding a Q2 non‑frequent licensing gain, Q3 EBITDA improved 10%. The company leveraged mixed feed assets, supply‑chain cost improvements and a transformation program that realized US$300 Mn year‑to‑date. G&A costs improved by 8%; the company targets US$3 Bn EBITDA impact by 2030. Global GDP growth for 2025 is estimated at 2.7%, and capital investment for 2025 is expected to be US$3.0–3.5 Bn.
Source: sabic.com